Strategies to strengthen the resilience of primary health care in the COVID-19 pandemic: a scoping review.

Strategies to strengthen the resilience of primary health care in the COVID-19 pandemic: a scoping review.

Publication date: Jul 25, 2024

Primary Health Care (PHC) systems are pivotal in delivering essential health services during crises, as demonstrated during the COVID-19 pandemic. With varied global strategies to reinforce PHC systems, this scoping review consolidates these efforts, identifying and categorizing key resilience-building strategies. Adopting Arksey and O’Malley’s scoping review framework, this study synthesized literature across five databases and Google Scholar, encompassing studies up to December 31st, 2022. We focused on English and Persian studies that addressed interventions to strengthen PHC amidst COVID-19. Data were analyzed through thematic framework analysis employing MAXQDA 10 software. Our review encapsulated 167 studies from 48 countries, revealing 194 interventions to strengthen PHC resilience, categorized into governance and leadership, financing, workforce, infrastructures, information systems, and service delivery. Notable strategies included telemedicine, workforce training, psychological support, and enhanced health information systems. The diversity of the interventions reflects a robust global response, emphasizing the adaptability of strategies across different health systems. The study underscored the need for well-resourced, managed, and adaptable PHC systems, capable of maintaining continuity in health services during emergencies. The identified interventions suggested a roadmap for integrating resilience into PHC, essential for global health security. This collective knowledge offered a strategic framework to enhance PHC systems’ readiness for future health challenges, contributing to the overall sustainability and effectiveness of global health systems.

Open Access PDF

Concepts Keywords
December COVID-19
Google COVID-19
Pandemic Crisis
Persian Humans
Training Leadership
Pandemic
Pandemics
Primary Health Care
Resilience
Resilience, Psychological
SARS-CoV-2
Strengthening strategies
Telemedicine

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease MESH emergencies
disease VO effectiveness
drug DRUGBANK Serine
drug DRUGBANK Coenzyme M
disease VO organization
disease VO effective
disease VO Equity
disease IDO quality
drug DRUGBANK Water
disease MESH infection
disease VO volume
drug DRUGBANK Tretamine
disease MESH SID
disease IDO process
disease VO publication
disease IDO country
disease VO document
drug DRUGBANK Indoleacetic acid
disease VO Canada
disease VO population
disease VO vaccination
disease VO immunization
disease VO efficient
drug DRUGBANK Isoxaflutole
drug DRUGBANK Trestolone
drug DRUGBANK Etoperidone
disease IDO facility
disease MESH job stress
disease VO storage
disease VO vaccine
disease VO time
disease MESH non communicable diseases
drug DRUGBANK Esomeprazole
drug DRUGBANK Huperzine B
disease VO Gap
drug DRUGBANK Amlodipine
disease IDO contact tracing
disease MESH Long COVID
disease IDO blood
drug DRUGBANK Nonoxynol-9
drug DRUGBANK Roxithromycin
disease IDO intervention
disease VO pregnant women
disease MESH influenza
disease MESH Infectious Diseases
disease MESH AIDS
disease MESH tuberculosis
pathway KEGG Tuberculosis
drug DRUGBANK Nadide
disease MESH Chronic Conditions
disease VO device
drug DRUGBANK Polyethylene glycol
disease MESH Developmental Disabilities
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH Burnout
drug DRUGBANK Ferrous sulfate anhydrous
disease VO organ
drug DRUGBANK Tropicamide
disease VO report
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Methylphenidate
drug DRUGBANK Spinosad

Original Article

(Visited 2 times, 1 visits today)